Brief: Cogent Bio Announces Oversubscribed $225 Million Private Placement
Feb 14 (Reuters) - Cogent Biosciences Inc COGT.O :
* COGENT BIOSCIENCES ANNOUNCES OVERSUBSCRIBED $225 MILLION
PRIVATE
PLACEMENT
* COGENT BIOSCIENCES INC- PRO-FORMA CASH, CASH EQUIVALENTS
AND
MARKETABLE SECURITIES EXPECTED TO FUND COMPANY INTO 2027
* COGENT BIOSCIENCES -PURSUANT TO TERMS OF DEAL, COGENT WILL
SELL
17 MILLION SHARES OF COMMON STOCK AT $7.50 PER SHARE,
REPRESENTING PREMIUM OF ABOUT 37%
Source text for Eikon: ID:nGNX5WCKGb
Further company coverage: COGT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cogent Biosciences
See all newsBrief: Cogent Biosciences - Enters Commercial Supply Agreement With Hovione On Sept 1, 2026 - SEC Filing
Brief: Cogent Biosciences - May Offer Up To $400 Million In Common Stock Through Guggenheim Securities
Cogent Biosciences Q2 net loss widens on higher expenses
Brief: Cogent Biosciences Q2 Net Income USD -96.405 Million
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's